|
2024
|
Invention
|
Crystalline salts of n-ethyl-(5-fluoro-1h-indol-3-yl)-n-methylethan-1-amine.
The present disclos... |
|
|
Invention
|
Crystalline hydrochloride and fumarate salts of n-ethyl-2- (5-fluoro-1h-indol-3-yl)-n-methylethan... |
|
|
Invention
|
Crystalline salts of n-ethyl-(5-fluoro-1h-indol-3-yl)-n-methylethan-1-amine. NHNNHNNHNNHNNHNN-met... |
|
|
Invention
|
Methods of treating mood disorders.
Methods of treating mood disorders with compounds disclosed ... |
|
|
Invention
|
Crystalline salts of 2-phenyl-2-aminocyclohexan-1-one derivatives. RR)-2-(4-fluorophenyl)-2-(meth... |
|
|
Invention
|
Novel ergolines and methods of treating mood disorders. The present disclosure provides ergoline ... |
|
|
Invention
|
Negative allosteric modulators of glun2b receptors and methods of making and using the same. The ... |
|
2023
|
Invention
|
Synthesis of 2-phenyl-2-amino-cyclohexan-1-one derivatives. The present disclosure relates to a p... |
|
|
Invention
|
Methods of using trazodone to reverse the effects of 5-ht2a receptor agonists. The present disclo... |
|
|
Invention
|
Crystalline fumarate salts of n-ethyl-2-(5-fluoro-1h-indol-3-yl)-n-methylethan-1-amine. The prese... |
|
|
Invention
|
Crystalline hydrochloride salts of n-ethyl-2-(5-fluoro-1h-indol-3-yl)-n-methylethan-1-amine. The ... |
|
|
Invention
|
Crystalline salts of n-ethyl-(5-fluoro-1h-indol-3-yl)-n-methylethan-1-amine. The present disclosu... |
|
|
Invention
|
Phenalkylamines and methods of making and using the same. The present disclosure provides phenalk... |
|
|
Invention
|
Tryptamines and methods of treating mood disorders. Novel tryptamine compounds according to Formu... |
|
|
Invention
|
Pyridine derivatives for treating psychiatric disorders. 1234566 are as defined herein. It also r... |
|
|
Invention
|
(ampa-pam)-nmda receptor antagonist combination therapy for treatment of mental conditions and di... |
|
2022
|
Invention
|
Combinations of peripheral 5-ht2a receptor antagonists and central 5-ht2a receptor agonists.
Met... |
|
|
Invention
|
Combinations of peripheral 5-ht2a receptor antagonists and central 5-ht2a receptor agonists. Meth... |
|
|
G/S
|
Pharmaceuticals, namely, pharmaceutical and drug preparations and substances for use in treating ... |
|
|
Invention
|
Arylcyclohexylamine derivatives and their use in the treatment of psychiatric disorders.
Provide... |
|
|
Invention
|
Arylcyclohexylamine derivatives and their use in the treatment of psychiatric disorders. Provided... |
|
|
Invention
|
Methods of treating neuropsychiatric disorders.
The disclosure provides, in part, a method of tr... |
|
|
Invention
|
Methods of treating neuropsychiatric disorders. The disclosure provides, in part, a method of tre... |
|
|
Invention
|
Novel tryptamines and methods of treating mood disorders. Novel tryptamines and methods of treati... |
|
|
Invention
|
Novel ergolines and methods of treating mood disorders.
The present disclosure provides ergoline... |
|
|
Invention
|
Phenalkylamines and methods of making and using the same.
The present disclosure provides phenal... |
|
2021
|
Invention
|
Methods of treating mood disorders. Methods of treating mood disorders with compounds disclosed h... |
|
|
Invention
|
Azetidinyl tryptamines and methods of treating psychiatric disorders.
The present disclosure inc... |
|
|
Invention
|
Azetidinyl tryptamines and methods of treating psychiatric disorders. The present disclosure incl... |
|
|
Invention
|
Phenalkylamines and methods of treating mood disorders. Phenalkylamines and methods of treating m... |
|
|
Invention
|
Phenalkylamines and methods of treating mood disorders.
Phenalkylamines and methods of treating ... |
|
|
Invention
|
Specific tryptamines for use in the treatment of mood disorders. Methods of treating mood disorde... |
